LBF20207OX01: Difference between revisions
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism= | |Metabolism= | ||
|Symbol=15-OxoEDE/15-KEDE | |||
|Biological Activity=15-OxoEDE is produced by the oxidation of 15-HEDE. Some other oxo-eicosanoids have been shown to be biosynthesized and to have potent inflammatory activity [[Reference:Powell_WS:Gravelle_F:Gravel_S:,J. Biol. Chem.,1992,267,19233|{{RelationTable/GetFirstAuthor|Reference:Powell_WS:Gravelle_F:Gravel_S:,J. Biol. Chem.,1992,267,19233}}]]. | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Revision as of 06:00, 7 January 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | DFA8155 |
| LipidMaps | LMFA01060073 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207OX01 |
| 15-oxo-11Z,13E-eicosadienoic acid | |
|---|---|
| |
| Structural Information | |
| 15-oxo-11Z,13E-eicosadienoic acid | |
| |
| 15-OxoEDE/15-KEDE | |
| Formula | C20H34O3 |
| Exact Mass | 322.25079495399996 |
| Average Mass | 322.48216 |
| SMILES | C(CCC(C=CC=CCCCCCCCCCC(O)=O)=O)CC |
| Physicochemical Information | |
| 15-OxoEDE is produced by the oxidation of 15-HEDE. Some other oxo-eicosanoids have been shown to be biosynthesized and to have potent inflammatory activity Powell_WS et al.. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | lmax: 279nm e: 23,000 |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
